Manja Boerman compensation by year
Catalent Summary Compensation Table · the one fiscal year held| Component | FY2023 |
|---|---|
| Salary | $511,387 |
| Bonus | $0 |
| Stock awards | $2,455,217 |
| Option awards | $195,022 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $818,262 |
| Total | $3,979,888 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Catalent, Inc. DEF 14A filed December 15, 2023, accession 0001193125-23-295996, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 900,000 | $1,521,022 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Catalent, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
Catalent’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Alessandro Maselli | President and Chief Executive Officer | $6,583,672 |
| John Chiminski | Former Executive Chair | $4,807,767 |
| Manja Boerman · this page | Former President, Division Head for Biomodalities | $3,979,888 |
| Aristippos Gennadios | Group President, Pharma and Consumer Health | $3,799,557 |
| Thomas Castellano | Former Senior Vice President and Chief Financial Officer | $2,729,983 |
| Steven Fasman | Former Executive Vice President & Chief Administrative Officer | $2,310,299 |
| Ricky Hopson | President, Division Head for Clinical Development & Supply and Former Interim Chief Financial Officer | $972,307 |
The full Catalent compensation record
free company briefThis page is one person within Catalent's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Catalent's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Catalent's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat